daritor-7.5 7.5 mg extended-release tablet
n/a; importer: torrent pharma philippines, inc.; distributor: torrent pharma philippines, inc. - darifenacin (as hydrobromide) - extended-release tablet - 7.5 mg
daritor-15 15 mg extended-release tablet
n/a; importer: torrent pharma philippines, inc.; distributor: torrent pharma philippines, inc. - darifenacin (as hydrobromide) - extended-release tablet - 15 mg
deritas 10
intas - derifenacin - 15mg - 10
deritas 10
intas - derifenacin - 7.5mg - 10
darif 10 tab
summit - darifenacin hbr - tab - 7.5mg - 10
darilong 5*10
sun - darifenacin hbr - 15mg - 5*10
darilong 5*10
sun - darifenacin hbr - 7.5mg - 5*10
enablex 7,5 mg tablet
pharmacare limited û woodmead - tablet - see ingredients - each tablet contains darifenacin hydrobromide equivalent to darifenacin 7,5 mg
enablex 15 mg tablet
pharmacare limited û woodmead - tablet - see ingredients - each tablet contains darifenacin 15,0 mg
itrazole
viatris limited - itraconazole 100mg; - capsule - 100 mg - active: itraconazole 100mg excipient: capsugel red g60csa00150 colloidal silicon dioxide ethanol gelatin hypromellose iron oxide red methylene chloride opacode white s-1-7078 purified water sorbitan stearate sugar spheres titanium dioxide - itraconazole capsules are indicated for the treatment of: · vulvovaginal candidiasis. · pityriasis versicolor, · dermatomycosis - including highly keratinised regions as in plantar tinea pedis and palmer tinea manus, · fungal keratitis, · oral candidiasis, · onychomycosis caused by dermatophytes and/or yeasts. · systemic mycoses, only in the following fungal infections: - systemic aspergillosis - histoplasmosis, - histoplasmosis, maintenance therapy only in aids patients - sporotrichosis (including lymphocutaneous/cutaneous and extracutaneous) - paraconccidioidomycosis, - chromomycosis, - blastomycosis